<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37426642</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>18</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Exploring the potential common denominator pathogenesis of system lupus erythematosus with COVID-19 based on comprehensive bioinformatics analysis.</ArticleTitle><Pagination><StartPage>1179664</StartPage><MedlinePgn>1179664</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1179664</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1179664</ELocationID><Abstract><AbstractText Label="OBJECTIVE">Evidences show that there may be a link between SLE and COVID-19. The purpose of this study is to screen out the diagnostic biomarkers of systemic lupus erythematosus (SLE) with COVID-19 and explore the possible related mechanisms by the bioinformatics approach.</AbstractText><AbstractText Label="METHODS">SLE and COVID-19 datasets were extracted separately from the NCBI Gene Expression Omnibus (GEO) database. The limma package in <i>R</i> was used to obtain the differential genes (DEGs). The protein interaction network information (PPI) and core functional modules were constructed in the STRING database using Cytoscape software. The hub genes were identified by the Cytohubba plugin, and TF-gene together with TF-miRNA regulatory networks were constructed <i>via</i> utilizing the Networkanalyst platform. Subsequently, we generated subject operating characteristic curves (ROC) to verify the diagnostic capabilities of these hub genes to predict the risk of SLE with COVID-19 infection. Finally, a single-sample gene set enrichment (ssGSEA) algorithm was used to analyze immune cell infiltration.</AbstractText><AbstractText Label="RESULTS">A total of 6 common hub genes (<i>CDC6, PLCG1, KIF15, LCK, CDC25C</i>, and <i>RASGRP1</i>) were identified with high diagnostic validity. These gene functional enrichments were mainly involved in cell cycle, and inflammation-related pathways. Compared to the healthy controls, abnormal infiltration of immune cells was found in SLE and COVID-19, and the proportion of immune cells linked to the 6 hub genes.</AbstractText><AbstractText Label="CONCLUSION">Our research logically identified 6 candidate hub genes that could predict SLE complicated with COVID-19. This work provides a foothold for further study of potential pathogenesis in SLE and COVID-19.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Zeng, Zhuang, Li, Yin, Huang and Peng.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Huiqiong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Futian District, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhuang</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Immunology, Huizhou Central People's Hospital, Huizhou, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xiaojuan</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Public Health, Shenzhen Hospital of Southern Medical University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Zhihua</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Futian District, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Xia</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Xi Yuan Community Health Service Center, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Haiyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Shenzhen Futian Hospital for Rheumatic Diseases, Futian District, Shenzhen, Guangdong, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>06</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C486567">KIF15 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.4</RegistryNumber><NameOfSubstance UI="D016547">Kinesins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018816" MajorTopicYN="N">Genes, cdc</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002453" MajorTopicYN="N">Cell Cycle</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019295" MajorTopicYN="N">Computational Biology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016547" MajorTopicYN="N">Kinesins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">bioinformatics</Keyword><Keyword MajorTopicYN="N">diagnostic biomarkers</Keyword><Keyword MajorTopicYN="N">immune cells infiltration</Keyword><Keyword MajorTopicYN="N">system lupus erythematosus</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The handling editor MZ declared a shared parent affiliation with the author YZ at the time of review.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>11</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>10</Day><Hour>5</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37426642</ArticleId><ArticleId IdType="pmc">PMC10325730</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1179664</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Muralidar S, Ambi SV, Sekaran S, Krishnan UM. The emergence of COVID-19 as a global pandemic: understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2. Biochimie (2020) 179:85&#x2013;100. doi:&#xa0;10.1016/j.biochi.2020.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2020.09.018</ArticleId><ArticleId IdType="pmc">PMC7505773</ArticleId><ArticleId IdType="pubmed">32971147</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Zhang H, Zhang W. SARS-CoV-2 variants, immune escape, and countermeasures. Front Med (2022) 16(2):196&#x2013;207. doi:&#xa0;10.1007/s11684-021-0906-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-021-0906-x</ArticleId><ArticleId IdType="pmc">PMC8898658</ArticleId><ArticleId IdType="pubmed">35253097</ArticleId></ArticleIdList></Reference><Reference><Citation>
WHO . Coronavirus disease (COVID-19) dashboard. Available at: https://covid19.who.int/ (Accessed 24 Jan Oct 2023).</Citation></Reference><Reference><Citation>Mallah SI, Ghorab OK, Al-Salmi S, Abdellatif OS, Tharmaratnam T, Iskandar MA, et al. . COVID-19: breaking down a global health crisis. Ann Clin Microbiol Antimicrob (2021) 20(1):35. doi:&#xa0;10.1186/s12941-021-00438-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12941-021-00438-7</ArticleId><ArticleId IdType="pmc">PMC8129964</ArticleId><ArticleId IdType="pubmed">34006330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med (2020) 172(11):ITC81&#x2013;96. doi:&#xa0;10.7326/AITC202006020</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/AITC202006020</ArticleId><ArticleId IdType="pubmed">32479157</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L, Lu MP, Wang JH, Xu M, Yang SR. Immunological pathogenesis and treatment of systemic lupus erythematosus. World J Pediatr (2020) 16(1):19&#x2013;30. doi:&#xa0;10.1007/s12519-019-00229-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-019-00229-3</ArticleId><ArticleId IdType="pmc">PMC7040062</ArticleId><ArticleId IdType="pubmed">30796732</ArticleId></ArticleIdList></Reference><Reference><Citation>Fatoye F, Gebrye T, Mbada C. Global and regional prevalence and incidence of systemic lupus erythematosus in low-and-middle income countries: a systematic review and meta-analysis. Rheumatol Int (2022) 42(12):2097&#x2013;107. doi:&#xa0;10.1007/s00296-022-05183-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-022-05183-4</ArticleId><ArticleId IdType="pmc">PMC9548466</ArticleId><ArticleId IdType="pubmed">36006459</ArticleId></ArticleIdList></Reference><Reference><Citation>Caso F, Costa L, Ruscitti P, Navarini L, Del Puente A, Giacomelli R, et al. . Could sars-coronavirus-2 trigger autoimmune and/or autoinflammatory mechanisms in genetically predisposed subjects? Autoimmun Rev (2020) 19(5):102524. doi:&#xa0;10.1016/j.autrev.2020.102524</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102524</ArticleId><ArticleId IdType="pmc">PMC7271072</ArticleId><ArticleId IdType="pubmed">32220633</ArticleId></ArticleIdList></Reference><Reference><Citation>Misra DP, Agarwal V, Gasparyan AY, Zimba O. Rheumatologists&#x2019; perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets. Clin Rheumatol (2020) 39(7):2055&#x2013;62. doi:&#xa0;10.1007/s10067-020-05073-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05073-9</ArticleId><ArticleId IdType="pmc">PMC7145936</ArticleId><ArticleId IdType="pubmed">32277367</ArticleId></ArticleIdList></Reference><Reference><Citation>Pablos JL, Galindo M, Carmona L, Lled&#xf3; A, Retuerto M, Blanco R, et al. . Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study. Ann Rheum Dis (2020) 79(12):1544&#x2013;9. doi:&#xa0;10.1136/annrheumdis-2020-218296</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2020-218296</ArticleId><ArticleId IdType="pubmed">32796045</ArticleId></ArticleIdList></Reference><Reference><Citation>Santos CS, Morales CM, &#xc1;lvarez ED, Castro C&#xc1;, Robles AL, Sandoval TP. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease. Clin Rheumatol (2020) 39(9):2789&#x2013;96. doi:&#xa0;10.1007/s10067-020-05301-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-020-05301-2</ArticleId><ArticleId IdType="pmc">PMC7383119</ArticleId><ArticleId IdType="pubmed">32720259</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamani B, Moeini Taba SM, Shayestehpour M. Systemic lupus erythematosus manifestation following COVID-19: a case report. J Med Case Rep (2021) 15(1):29. doi:&#xa0;10.1186/s13256-020-02582-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13256-020-02582-8</ArticleId><ArticleId IdType="pmc">PMC7832415</ArticleId><ArticleId IdType="pubmed">33494816</ArticleId></ArticleIdList></Reference><Reference><Citation>Kudose S, Batal I, Santoriello D, Xu K, Barasch J, Peleg Y, et al. . Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol (2020) 31(9):1959&#x2013;68. doi:&#xa0;10.1681/ASN.2020060802</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020060802</ArticleId><ArticleId IdType="pmc">PMC7461665</ArticleId><ArticleId IdType="pubmed">32680910</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;vy Y, Wiedemann A, Hejblum BP, Durand M, Lefebvre C, Sur&#xe9;naud M, et al. . French COVID cohort study group. CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death. iScience (2021) 24(7):102711. doi:&#xa0;10.1016/j.isci.2021.102711</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102711</ArticleId><ArticleId IdType="pmc">PMC8189740</ArticleId><ArticleId IdType="pubmed">34127958</ArticleId></ArticleIdList></Reference><Reference><Citation>Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, et al. . An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature (2010) 466(7309):973&#x2013;7. doi:&#xa0;10.1038/nature09247</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09247</ArticleId><ArticleId IdType="pmc">PMC3492754</ArticleId><ArticleId IdType="pubmed">20725040</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Wong L, Chua HN. Complex discovery from weighted PPI networks. Bioinformatics (2009) 25(15):1891&#x2013;7. doi:&#xa0;10.1093/bioinformatics/btp311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp311</ArticleId><ArticleId IdType="pubmed">19435747</ArticleId></ArticleIdList></Reference><Reference><Citation>Lotia S, Montojo J, Dong Y, Bader GD, Pico AR. Cytoscape app store. Bioinformatics (2013) 29(10):1350&#x2013;1. doi:&#xa0;10.1093/bioinformatics/btt138</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt138</ArticleId><ArticleId IdType="pmc">PMC3654709</ArticleId><ArticleId IdType="pubmed">23595664</ArticleId></ArticleIdList></Reference><Reference><Citation>Franz M, Rodriguez H, Lopes C, Zuberi K, Montojo J, Bader GD, et al. . GeneMANIA update 2018. Nucleic Acids Res (2018) 46(W1):W60&#x2013;4. doi:&#xa0;10.1093/nar/gky311</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky311</ArticleId><ArticleId IdType="pmc">PMC6030815</ArticleId><ArticleId IdType="pubmed">29912392</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambert SA, Jolma A, Campitelli LF, Das PK, Yin Y, Albu M, et al. . The human transcription factors. Cell (2018) 172(4):650&#x2013;65. doi:&#xa0;10.1016/j.cell.2018.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.01.029</ArticleId><ArticleId IdType="pubmed">29425488</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou G, Soufan O, Ewald J, Hancock REW, Basu N, Xia J. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res (2019) 47(W1):W234&#x2013;41. doi:&#xa0;10.1093/nar/gkz240</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz240</ArticleId><ArticleId IdType="pmc">PMC6602507</ArticleId><ArticleId IdType="pubmed">30931480</ArticleId></ArticleIdList></Reference><Reference><Citation>Coscia F, Lengyel E, Duraiswamy J, Ashcroft B, Bassani-Sternberg M, Wierer M, et al. . Multi-level proteomics identifies CT45 as a chemosensitivity mediator and immunotherapy target in ovarian cancer. Cell (2018) 175(1):159&#x2013;170.e16. doi:&#xa0;10.1016/j.cell.2018.08.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.08.065</ArticleId><ArticleId IdType="pmc">PMC6827878</ArticleId><ArticleId IdType="pubmed">30241606</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson P, Rylance P, Roden D, Trela M, Tugnet N. Viruses as potential pathogenic agents in systemic lupus erythematosus. Lupus (2014) 23(6):596&#x2013;605. doi:&#xa0;10.1177/0961203314531637</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203314531637</ArticleId><ArticleId IdType="pubmed">24763543</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatol (Oxford) (2001) 40(2):152&#x2013;7. doi:&#xa0;10.1093/rheumatology/40.2.152</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/40.2.152</ArticleId><ArticleId IdType="pubmed">11257151</ArticleId></ArticleIdList></Reference><Reference><Citation>Jog NR, James JA. Epstein Barr Virus and autoimmune responses in systemic lupus erythematosus. Front Immunol (2021) 3:623944. doi:&#xa0;10.3389/fimmu.2020.623944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.623944</ArticleId><ArticleId IdType="pmc">PMC7886683</ArticleId><ArticleId IdType="pubmed">33613559</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekigawa I, Ogasawara H, Kaneko H, Hishikawa T, Hashimoto H. Retroviruses and autoimmunity. Intern Med (2001) 40(2):80&#x2013;6. doi:&#xa0;10.2169/internalmedicine.40.80</Citation><ArticleIdList><ArticleId IdType="doi">10.2169/internalmedicine.40.80</ArticleId><ArticleId IdType="pubmed">11300167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Yao B, Yan M, Su KE, Wang H, Xu C. The plight of patients with lupus nephritis during the outbreak of COVID-19 in wuhan, China. J Rheumatol (2020) 47(9):1452. doi:&#xa0;10.3899/jrheum.200452</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.200452</ArticleId><ArticleId IdType="pubmed">32385088</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugarte-Gil MF, Alarc&#xf3;n GS, Izadi Z, Duarte-Garc&#xed;a A, Re&#xe1;tegui-Sokolova C, Clarke AE, et al. . Characteristics associated with poor COVID-19 outcomes in individuals with systemic lupus erythematosus: data from the COVID-19 global rheumatology alliance. Ann Rheum Dis (2022) 81(7):970&#x2013;8. doi:&#xa0;10.1136/annrheumdis-2021-221636</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-221636</ArticleId><ArticleId IdType="pmc">PMC8882632</ArticleId><ArticleId IdType="pubmed">35172961</ArticleId></ArticleIdList></Reference><Reference><Citation>Raiker R, Pakhchanian H, DeYoung C, Gupta L, Karde&#x15f; S, Ahmed S, et al. . Short term outcomes of COVID-19 in lupus: propensity score matched analysis from a nationwide multi-centric research network. J Autoimmun (2021) 125:102730. doi:&#xa0;10.1016/j.jaut.2021.102730</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2021.102730</ArticleId><ArticleId IdType="pmc">PMC8501265</ArticleId><ArticleId IdType="pubmed">34649723</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamers MM, Haagmans BL. SARS-CoV-2 pathogenesis. Nat Rev Microbiol (2022) 20(5):270&#x2013;84. doi:&#xa0;10.1038/s41579-022-00713-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00713-0</ArticleId><ArticleId IdType="pubmed">35354968</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsokos GC, Lo MS, Costa Reis P, Sullivan KE. New insights into the immunopathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol (2016) 12(12):716&#x2013;30. doi:&#xa0;10.1038/nrrheum.2016.186</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2016.186</ArticleId><ArticleId IdType="pubmed">27872476</ArticleId></ArticleIdList></Reference><Reference><Citation>Bastard P, Rosen LB, Zhang Q, Michailidis E, Hoffmann HH, Zhang Y, et al. . Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science (2020) 370(6515):eabd4585. doi:&#xa0;10.1126/science.abd4585</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd4585</ArticleId><ArticleId IdType="pmc">PMC7857397</ArticleId><ArticleId IdType="pubmed">32972996</ArticleId></ArticleIdList></Reference><Reference><Citation>Chasset F, Arnaud L. Targeting interferons and their pathways in systemic lupus erythematosus. Autoimmun Rev (2018) 17(1):44&#x2013;52. doi:&#xa0;10.1016/j.autrev.2017.11.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.11.009</ArticleId><ArticleId IdType="pubmed">29108825</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew D, Giles JR, Baxter AE, Oldridge DA, Greenplate AR, Wu JE, et al. . Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science (2020) 369(6508):eabc8511. doi:&#xa0;10.1126/science.abc8511</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc8511</ArticleId><ArticleId IdType="pmc">PMC7402624</ArticleId><ArticleId IdType="pubmed">32669297</ArticleId></ArticleIdList></Reference><Reference><Citation>Yunis J, Short KR, Yu D. Severe respiratory viral infections: T-cell functions diverging from immunity to inflammation. Trends Microbiol (2023) 31(6):644&#x2013;56. doi:&#xa0;10.1016/j.tim.2022.12.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2022.12.008</ArticleId><ArticleId IdType="pmc">PMC9829516</ArticleId><ArticleId IdType="pubmed">36635162</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccolo E, Innominato PF, Mariggio MA, Maffucci T, Iacobelli S, Falasca M. The mechanism involved in the regulation of phospholipase Cgamma1 activity in cell migration. Oncogene (2002) 21(42):6520&#x2013;9. doi:&#xa0;10.1038/sj.onc.1205821</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1205821</ArticleId><ArticleId IdType="pubmed">12226755</ArticleId></ArticleIdList></Reference><Reference><Citation>Poissonnier A, Sans&#xe9;au D, Le Gallo M, Malleter M, Levoin N, Viel R, et al. . CD95-mediated calcium signaling promotes T helper 17 trafficking to inflamed organs in lupus-prone mice. Immunity (2016) 45(1):209&#x2013;23. doi:&#xa0;10.1016/j.immuni.2016.06.028</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2016.06.028</ArticleId><ArticleId IdType="pmc">PMC4961226</ArticleId><ArticleId IdType="pubmed">27438772</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheshenko N, Bonanno JB, Hoffmann HH, Jangra RK, Chandran K, Rice CM, et al. . Cell-impermeable staurosporine analog targets extracellular kinases to inhibit HSV and SARS-CoV-2. Commun Biol (2022) 5(1):1096. doi:&#xa0;10.1038/s42003-022-04067-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-022-04067-4</ArticleId><ArticleId IdType="pmc">PMC9569420</ArticleId><ArticleId IdType="pubmed">36245045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu TC, Rodrigues GOL, Winer H, Hixon JA, Li W, Tarasova NI, et al. . A focused review of ras guanine nucleotide-releasing protein 1 in immune cells and cancer. Int J Mol Sci (2023) 24(2):1652. doi:&#xa0;10.3390/ijms24021652</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021652</ArticleId><ArticleId IdType="pmc">PMC9864139</ArticleId><ArticleId IdType="pubmed">36675167</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannawi S, Alqutami F, Hachim MY. POS1223 RAS GUANYL RELEASING PROTEIN 1 (RASGRP1) IN PERIPHERAL b CELLS LINKS RA TO COVID-19. Ann Rheumatic Dis (2021) 80:895. doi: 10.1136/annrheumdis-2021-eular.2809</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2021-eular.2809</ArticleId></ArticleIdList></Reference><Reference><Citation>Molineros JE, Singh B, Terao C, Okada Y, Kaplan J, McDaniel B, et al. . Mechanistic characterization of RASGRP1 variants identifies an hnRNP-K-Regulated transcriptional enhancer contributing to SLE susceptibility. Front Immunol (2019) 20:1066. doi:&#xa0;10.3389/fimmu.2019.01066</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01066</ArticleId><ArticleId IdType="pmc">PMC6536009</ArticleId><ArticleId IdType="pubmed">31164884</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu E, Chia CPZ, Chen W, Zhang D, Park SA, Jin W, et al. . T Cell receptor-regulated TGF-&#x3b2; type I receptor expression determines T cell quiescence and activation. Immunity (2018) 48(4):745&#x2013;759.e6. doi:&#xa0;10.1016/j.immuni.2018.03.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2018.03.025</ArticleId><ArticleId IdType="pmc">PMC5911925</ArticleId><ArticleId IdType="pubmed">29669252</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosetti F, Madera-Salcedo IK, Rodr&#xed;guez-Rodr&#xed;guez N, Crisp&#xed;n JC. Regulation of activated T cell survival in rheumatic autoimmune diseases. Nat Rev Rheumatol (2022) 18(4):232&#x2013;44. doi:&#xa0;10.1038/s41584-021-00741-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-021-00741-9</ArticleId><ArticleId IdType="pubmed">35075294</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Luo S, Qin R, Yang M, Wang X, Yang Q, et al. . Long-term infection of SARS-CoV-2 changed the body&#x2019;s immune status. Clin Immunol (2020) 218:108524. doi:&#xa0;10.1016/j.clim.2020.108524</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2020.108524</ArticleId><ArticleId IdType="pmc">PMC7351676</ArticleId><ArticleId IdType="pubmed">32659373</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh C, Luong G, Sun Y. A snapshot of the PD-1/PD-L1 pathway. J Cancer (2021) 12(9):2735&#x2013;46. doi:&#xa0;10.7150/jca.57334</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/jca.57334</ArticleId><ArticleId IdType="pmc">PMC8040720</ArticleId><ArticleId IdType="pubmed">33854633</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee YH, Woo JH, Choi SJ, Ji JD, Song GG. Association of programmed cell death 1 polymorphisms and systemic lupus erythematosus: a meta-analysis. Lupus (2009) 18(1):9&#x2013;15. doi:&#xa0;10.1177/0961203308093923</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203308093923</ArticleId><ArticleId IdType="pubmed">19074163</ArticleId></ArticleIdList></Reference><Reference><Citation>Curran CS, Gupta S, Sanz I, Sharon E. PD-1 immunobiology in systemic lupus erythematosus. J Autoimmun (2019) 97:1&#x2013;9. doi:&#xa0;10.1016/j.jaut.2018.10.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2018.10.025</ArticleId><ArticleId IdType="pmc">PMC7449827</ArticleId><ArticleId IdType="pubmed">30396745</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang CL, Jiang H, Feng W, Liu H, Han L, Chen Y, et al. . Total glucosides of paeony ameliorate pristane-induced lupus nephritis by inducing PD-1 ligands+ macrophages via activating IL-4/STAT6/PD-L2 signaling. Front Immunol (2021) 5:683249. doi:&#xa0;10.3389/fimmu.2021.683249</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.683249</ArticleId><ArticleId IdType="pmc">PMC8288191</ArticleId><ArticleId IdType="pubmed">34290705</ArticleId></ArticleIdList></Reference><Reference><Citation>Han X, Vesely MD, Yang W, Sanmamed MF, Badri T, Alawa J, et al. . PD-1H (VISTA)-mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus. Sci Transl Med (2019) 11(522):eaax1159. doi:&#xa0;10.1126/scitranslmed.aax1159</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aax1159</ArticleId><ArticleId IdType="pubmed">31826980</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonam S R, Hu H, Bayry J. Role of the PD-1 and PD-L1 axis in COVID-19. Future Microbiol (2022) 17:985&#x2013;8. doi:&#xa0;10.2217/fmb-2022-0103</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/fmb-2022-0103</ArticleId><ArticleId IdType="pmc">PMC9332906</ArticleId><ArticleId IdType="pubmed">35899493</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbatino F, Conti V, Franci G, Sellitto C, Manzo V, Pagliano P, et al. . PD-L1 dysregulation in COVID-19 patients. Front Immunol (2021) 7:695242. doi:&#xa0;10.3389/fimmu.2021.695242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.695242</ArticleId><ArticleId IdType="pmc">PMC8215357</ArticleId><ArticleId IdType="pubmed">34163490</ArticleId></ArticleIdList></Reference><Reference><Citation>Nied&#x17a;wiedzka-Rystwej P, Majchrzak A, Aksak-W&#x105;s B, Serwin K, Czajkowski Z, Grywalska E, et al. . Programmed cell death-1/Programmed cell death-1 ligand as prognostic markers of coronavirus disease 2019 severity. Cells (2022) 11(12):1978. doi:&#xa0;10.3390/cells11121978</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells11121978</ArticleId><ArticleId IdType="pmc">PMC9222173</ArticleId><ArticleId IdType="pubmed">35741107</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasanvand A. COVID-19 and the role of cytokines in this disease. Inflammopharmacology (2022) 30(3):789&#x2013;98. doi:&#xa0;10.1007/s10787-022-00992-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-022-00992-2</ArticleId><ArticleId IdType="pmc">PMC9064717</ArticleId><ArticleId IdType="pubmed">35505267</ArticleId></ArticleIdList></Reference><Reference><Citation>Park JJ, Lee KAV, Lam SZ, Moon KS, Fang Z, Chen S. Machine learning identifies T cell receptor repertoire signatures associated with COVID-19 severity. Commun Biol (2023) 6(1):76. doi:&#xa0;10.1038/s42003-023-04447-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42003-023-04447-4</ArticleId><ArticleId IdType="pmc">PMC9853487</ArticleId><ArticleId IdType="pubmed">36670287</ArticleId></ArticleIdList></Reference><Reference><Citation>Brownlie RJ, Zamoyska R. T Cell receptor signalling networks: branched, diversified and bounded. Nat Rev Immunol (2013) 13(4):257&#x2013;69. doi:&#xa0;10.1038/nri3403</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3403</ArticleId><ArticleId IdType="pubmed">23524462</ArticleId></ArticleIdList></Reference><Reference><Citation>Attiq A, Yao LJ, Afzal S, Khan MA. The triumvirate of NF-&#x3ba;B, inflammation and cytokine storm in COVID-19. Int Immunopharmacol (2021) 101(Pt B):108255. doi:&#xa0;10.1016/j.intimp.2021.108255</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.108255</ArticleId><ArticleId IdType="pmc">PMC8516728</ArticleId><ArticleId IdType="pubmed">34688149</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong X, Zhang Z, Fu T, Ji J, Yang J, Gu Z. TNF-&#x3b1; regulates microglial activation via the NF-&#x3ba;B signaling pathway in systemic lupus erythematosus with depression. Int J Biol Macromol (2019) 15:125:892&#x2013;900. doi:&#xa0;10.1016/j.ijbiomac.2018.12.146</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2018.12.146</ArticleId><ArticleId IdType="pubmed">30572037</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu HX, Fan XP, Li M, Liu MJ, Sun QL. MiR-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating NF-&#x3ba;B pathway. Eur Rev Med Pharmacol Sci (2019) 23(16):7024&#x2013;32. doi:&#xa0;10.26355/eurrev_201908_18744</Citation><ArticleIdList><ArticleId IdType="doi">10.26355/eurrev_201908_18744</ArticleId><ArticleId IdType="pubmed">31486503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao X, Li S, Wang Z, Bai N, Feng Y. miR-101-3p negatively regulates inflammation in systemic lupus erythematosus via MAPK1 targeting and inhibition of the NF-&#x3ba;B pathway. Mol Med Rep (2021) 23(5):359. doi:&#xa0;10.3892/mmr.2021.11998</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2021.11998</ArticleId><ArticleId IdType="pubmed">33760166</ArticleId></ArticleIdList></Reference><Reference><Citation>Davitt E, Davitt C, Mazer MB, Areti SS, Hotchkiss RS, Remy KE. COVID-19 disease and immune dysregulation. Best Pract Res Clin Haematol (2022) 35(3):101401. doi:&#xa0;10.1016/j.beha.2022.101401</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beha.2022.101401</ArticleId><ArticleId IdType="pmc">PMC9568269</ArticleId><ArticleId IdType="pubmed">36494149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gusev E, Sarapultsev A, Solomatina L, Chereshnev V. SARS-CoV-2-Specific immune response and the pathogenesis of COVID-19. Int J Mol Sci (2022) 23(3):1716. doi:&#xa0;10.3390/ijms23031716</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031716</ArticleId><ArticleId IdType="pmc">PMC8835786</ArticleId><ArticleId IdType="pubmed">35163638</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao M, Liu Y, Yuan J, Wen Y, Xu G, Zhao J, et al. . Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nat Med (2020) 26(6):842&#x2013;4. doi:&#xa0;10.1038/s41591-020-0901-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0901-9</ArticleId><ArticleId IdType="pubmed">32398875</ArticleId></ArticleIdList></Reference><Reference><Citation>Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 11(8):519&#x2013;31. doi:&#xa0;10.1038/nri3024</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3024</ArticleId><ArticleId IdType="pubmed">21785456</ArticleId></ArticleIdList></Reference><Reference><Citation>Rada B. Neutrophil extracellular traps. Methods Mol Biol (2019) 1982:517&#x2013;28. doi:&#xa0;10.1007/978-1-4939-9424-3_31</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4939-9424-3_31</ArticleId><ArticleId IdType="pmc">PMC6874304</ArticleId><ArticleId IdType="pubmed">31172493</ArticleId></ArticleIdList></Reference><Reference><Citation>Fousert E, Toes R, Desai J. Neutrophil extracellular traps (NETs) take the central stage in driving autoimmune responses. Cells (2020) 9(4):915. doi:&#xa0;10.3390/cells9040915</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9040915</ArticleId><ArticleId IdType="pmc">PMC7226846</ArticleId><ArticleId IdType="pubmed">32276504</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. . Neutrophil extracellular traps in COVID-19. JCI Insight (2020) 5(11):e138999. doi:&#xa0;10.1172/jci.insight.138999</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.138999</ArticleId><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. . Neutrophil extracellular traps (NETs) as markers of disease severity in COVID-19. medRxiv (2020). doi:&#xa0;10.1101/2020.04.09.20059626</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2020.04.09.20059626</ArticleId></ArticleIdList></Reference><Reference><Citation>Pruchniak MP, Ostafin M, Wachowska M, Jakubaszek M, Kwiatkowska B, Olesinska M, et al. . Neutrophil extracellular traps generation and degradation in patients with granulomatosis with polyangiitis and systemic lupus erythematosus. Autoimmunity (2019) 52(3):126&#x2013;35. doi:&#xa0;10.1080/08916934.2019.1631812</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/08916934.2019.1631812</ArticleId><ArticleId IdType="pubmed">31257985</ArticleId></ArticleIdList></Reference><Reference><Citation>Villanueva E, Yalavarthi S, Berthier CC, Hodgin JB, Khandpur R, Lin AM, et al. . Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus. J Immunol (2011) 187(1):538&#x2013;52. doi:&#xa0;10.4049/jimmunol.1100450</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100450</ArticleId><ArticleId IdType="pmc">PMC3119769</ArticleId><ArticleId IdType="pubmed">21613614</ArticleId></ArticleIdList></Reference><Reference><Citation>Canny SP, Jackson SW. B cells in systemic lupus erythematosus: from disease mechanisms to targeted therapies. Rheum Dis Clin North Am (2021) 47(3):395&#x2013;413. doi:&#xa0;10.1016/j.rdc.2021.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rdc.2021.04.006</ArticleId><ArticleId IdType="pmc">PMC8357318</ArticleId><ArticleId IdType="pubmed">34215370</ArticleId></ArticleIdList></Reference><Reference><Citation>Clottu AS, Humbel M, Fluder N, Karampetsou MP, Comte D. Innate lymphoid cells in autoimmune diseases. Front Immunol (2022) 12:789788. doi:&#xa0;10.3389/fimmu.2021.789788</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.789788</ArticleId><ArticleId IdType="pmc">PMC8777080</ArticleId><ArticleId IdType="pubmed">35069567</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah K, Lee WW, Lee SH, Kim SH, Kang SW, Craft J, et al. . Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus. Arthritis Res Ther (2010) 12(2):R53. doi:&#xa0;10.1186/ar2964</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar2964</ArticleId><ArticleId IdType="pmc">PMC2888202</ArticleId><ArticleId IdType="pubmed">20334681</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffith M, Griffith OL, Coffman AC, Weible JV, McMichael JF, Spies NC, et al. . DGIdb: mining the druggable genome. Nat Methods (2013) 10(12):1209&#x2013;10. doi:&#xa0;10.1038/nmeth.2689</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2689</ArticleId><ArticleId IdType="pmc">PMC3851581</ArticleId><ArticleId IdType="pubmed">24122041</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>